表皮生长因子在皮肤科临床应用的安全性研究进展  

Safety of epidermal growth factor in dermatology

作　　者：彭霖[1] 林彤[1] 

机构地区：[1]中国医学科学院北京协和医学院皮肤病研究所,南京210042

出　　处：《中国麻风皮肤病杂志》2018年第2期118-121,共4页China Journal of Leprosy and Skin Diseases

基　　金：我国重点感染及炎症性皮肤性病的流行病学及防治研究(编号:CIFMS-2017-I2M-1-017)

摘　　要：表皮生长因子及其受体通路在上皮细胞增殖分化中发挥重要作用,表皮生长因子在皮肤科临床应用中主要作为外用制剂使用,红斑、瘙痒等不良反应发生率低且能耐受。本文就表皮生长因子在皮肤科临床应用的安全性进行综述。The epidermal growth factor and the signaling pathway play an important role in the proliferation and differentiation of epithelial cells. Epidermal growth factor is mainly used for topical application in dermatology. The incidence of adverse reactions such as erythema or pruritus is low and well-tolerated. The safety of epidermal growth factor in clinical application of dermatology is reviewed in this article.

关 键 词：表皮生长因子 皮肤科 安全性 

分 类 号：R739.5[医药卫生—肿瘤] R751[医药卫生—临床医学]